Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - Nasdaq - US12448X2018 - Common Stock - Currency: USD

31.57  +1.99 (+6.73%)

Premarket: 30.04 -1.53 (-4.85%)

Fundamental Rating

5

Taking everything into account, BYRN scores 5 out of 10 in our fundamental rating. BYRN was compared to 65 industry peers in the Aerospace & Defense industry. While BYRN has a great health rating, its profitability is only average at the moment. BYRN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year BYRN was profitable.
BYRN had a positive operating cash flow in the past year.
BYRN had negative earnings in 4 of the past 5 years.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

The Return On Assets of BYRN (20.34%) is better than 100.00% of its industry peers.
BYRN has a Return On Equity of 25.33%. This is amongst the best in the industry. BYRN outperforms 93.85% of its industry peers.
With an excellent Return On Invested Capital value of 11.42%, BYRN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA 20.34%
ROE 25.33%
ROIC 11.42%
ROA(3y)-3.81%
ROA(5y)-15.27%
ROE(3y)-4.15%
ROE(5y)-33.64%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN's Profit Margin of 15.15% is amongst the best of the industry. BYRN outperforms 92.31% of its industry peers.
BYRN's Operating Margin of 8.95% is in line compared to the rest of the industry. BYRN outperforms 58.46% of its industry peers.
With an excellent Gross Margin value of 61.97%, BYRN belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

8

2. Health

2.1 Basic Checks

BYRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BYRN remains at a similar level compared to 1 year ago.
BYRN has more shares outstanding than it did 5 years ago.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 31.95. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 31.95, BYRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.95
ROIC/WACC1.11
WACC10.27%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BYRN has a Current Ratio of 4.08. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
BYRN's Current ratio of 4.08 is fine compared to the rest of the industry. BYRN outperforms 80.00% of its industry peers.
A Quick Ratio of 2.17 indicates that BYRN has no problem at all paying its short term obligations.
BYRN's Quick ratio of 2.17 is fine compared to the rest of the industry. BYRN outperforms 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 2.17
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1700.00% over the past year.
The Revenue has grown by 87.24% in the past year. This is a very strong growth!
BYRN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 147.68% yearly.
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%

3.2 Future

Based on estimates for the next years, BYRN will show a small growth in Earnings Per Share. The EPS will grow by 1.20% on average per year.
The Revenue is expected to grow by 18.79% on average over the next years. This is quite good.
EPS Next Y-43.24%
EPS Next 2Y10.58%
EPS Next 3Y1.2%
EPS Next 5YN/A
Revenue Next Year31.67%
Revenue Next 2Y25.93%
Revenue Next 3Y23.43%
Revenue Next 5Y18.79%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.33, the valuation of BYRN can be described as expensive.
BYRN's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.60, BYRN is valued quite expensively.
Based on the Price/Forward Earnings ratio of 41.64, the valuation of BYRN can be described as expensive.
BYRN's Price/Forward Earnings is on the same level as the industry average.
BYRN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.39.
Industry RankSector Rank
PE 49.33
Fwd PE 41.64
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BYRN is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 67.67
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of BYRN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.58%
EPS Next 3Y1.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (6/12/2025, 8:00:02 PM)

Premarket: 30.04 -1.53 (-4.85%)

31.57

+1.99 (+6.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-10 2025-04-10/bmo
Earnings (Next)07-07 2025-07-07/bmo
Inst Owners52.81%
Inst Owner Change14.15%
Ins Owners19.38%
Ins Owner Change1.09%
Market Cap715.69M
Analysts84
Price Target36.34 (15.11%)
Short Float %19.06%
Short Ratio6.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)175.38%
Min EPS beat(2)96.08%
Max EPS beat(2)254.68%
EPS beat(4)4
Avg EPS beat(4)157.7%
Min EPS beat(4)47.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-2.94%
EPS beat(12)7
Avg EPS beat(12)-16.34%
EPS beat(16)9
Avg EPS beat(16)13.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)1.52%
Revenue beat(4)2
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)5.2%
Revenue beat(8)4
Avg Revenue beat(8)3.84%
Revenue beat(12)4
Avg Revenue beat(12)-1.38%
Revenue beat(16)6
Avg Revenue beat(16)1.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)67.13%
EPS NQ rev (3m)24.8%
EPS NY rev (1m)-10%
EPS NY rev (3m)-29.26%
Revenue NQ rev (1m)9.42%
Revenue NQ rev (3m)10.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.06%
Valuation
Industry RankSector Rank
PE 49.33
Fwd PE 41.64
P/S 7.51
P/FCF N/A
P/OCF 167.22
P/B 12.56
P/tB 13.91
EV/EBITDA 67.67
EPS(TTM)0.64
EY2.03%
EPS(NY)0.76
Fwd EY2.4%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.19
OCFY0.6%
SpS4.2
BVpS2.51
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.34%
ROE 25.33%
ROCE 14.46%
ROIC 11.42%
ROICexc 16.97%
ROICexgc 19.71%
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
FCFM N/A
ROA(3y)-3.81%
ROA(5y)-15.27%
ROE(3y)-4.15%
ROE(5y)-33.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 303.15%
Cap/Sales 5.06%
Interest Coverage 250
Cash Conversion 42.29%
Profit Quality N/A
Current Ratio 4.08
Quick Ratio 2.17
Altman-Z 31.95
F-Score7
WACC10.27%
ROIC/WACC1.11
Cap/Depr(3y)202.39%
Cap/Depr(5y)309.99%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y-43.24%
EPS Next 2Y10.58%
EPS Next 3Y1.2%
EPS Next 5YN/A
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%
Revenue Next Year31.67%
Revenue Next 2Y25.93%
Revenue Next 3Y23.43%
Revenue Next 5Y18.79%
EBIT growth 1Y243.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year234.99%
EBIT Next 3Y81.16%
EBIT Next 5Y53.44%
FCF growth 1Y95.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y148.8%
OCF growth 3YN/A
OCF growth 5YN/A